Materials & Resources » Chemicals | Phibro Animal Health Corp.

Phibro Animal Health Corp. | Income Statement

Fiscal year is July-June. All values USD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
691,914.00
748,591.00
751,526.00
764,281.00
819,982.00
Cost of Goods Sold (COGS) incl. D&A
489,036.00
516,779.00
512,494.00
517,049.00
554,568.00
Gross Income
202,878.00
231,812.00
239,032.00
247,232.00
265,414.00
SG&A Expense
139,084.00
144,144.00
152,670.00
155,833.00
167,553.00
EBIT
63,794.00
87,668.00
-
91,399.00
97,861.00
Unusual Expense
22,771.00
-
618.00
2,926.00
1,065.00
Non Operating Income/Expense
1,753.00
5,400.00
7,609.00
1,124.00
1,054.00
Interest Expense
33,081.00
14,554.00
16,848.00
16,872.00
13,603.00
Pretax Income
6,308.00
78,763.00
76,761.00
80,543.00
88,070.00
Income Tax
9,435.00
18,483.00
5,967.00
15,928.00
23,187.00
Consolidated Net Income
3,127.00
60,280.00
82,728.00
64,615.00
64,883.00
Net Income
3,127.00
60,280.00
82,728.00
64,615.00
64,883.00
Net Income After Extraordinaries
3,127.00
60,280.00
82,728.00
64,615.00
64,883.00
Net Income Available to Common
3,127.00
60,280.00
82,728.00
64,615.00
64,883.00
EPS (Basic)
0.10
1.51
2.07
1.61
1.61
Basic Shares Outstanding
32,200.00
38,969.00
39,254.00
39,524.00
40,181.00
EPS (Diluted)
0.10
1.51
2.07
1.61
1.61
Diluted Shares Outstanding
32,200.00
39,815.00
39,962.00
40,042.00
40,385.00
EBITDA
85,247.00
109,272.00
109,814.00
117,400.00
124,804.00
Non-Operating Interest Income
119.00
249.00
256.00
1,966.00
1,693.00

About Phibro Animal Health

View Profile
Address
Glenpointe Centre East
Teaneck New Jersey 07666
United States
Employees -
Website http://www.pahc.com
Updated 07/08/2019
Phibro Animal Health Corp. engages in the manufacture of animal health and mineral nutrition products. It operates through the following business segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops, manufactures, and markets antibacterial, nutritional specialty products, and vaccines.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.